Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • FEATURED
  • COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

COVID: One in every four persons have Covid-19 Antibodies in Kolkata

Genetic engineering- a potential weapon to kill?

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials to be resumed again

bioxone September 12, 2020September 12, 2020

-Anuska Sen, Team bioXone

On 10th September 2020, that is 2 days back, Team BioXone had covered a piece of news stating the pause of the Covid-19 vaccine of AstraZeneca by Serum Institute.

Today, it has been reported that once again, the trials for AstraZeneca’s Covid-19 vaccine has been successfully resumed. The one reason that the trials had been put on hold was an unexplained illness of one of the volunteers on whom the vaccine was administered.

AstraZeneca has confirmed that they have resumed their trials in the UK as it has been confirmed by different medical tests that the illness of the patient was not at all due to the administration of the vaccine and neither was it in any way related to the effects of the vaccine. A special committee was created to investigate the safety and other medical issues in the latest case, which has reported that the vaccine trials can be resumed safely in the UK.

However, as AstraZeneca says that it has never compromised with the safety of the trial volunteers and the level of conduct in its clinical trials, the trials had been “voluntarily” paused for high standard security purposes. Now that it has no other barriers in its way till now, as confirmed by Medicines Health Regulatory Authority (MHRA), the trials will be resumed soon.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged AstraZeneca Clinical trial Covid COVID trial COVID VACCINE TRIAL England india MHRA Oxford trials UK VACCINE vaccine trial

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

Genetic engineering- a potential weapon to kill?

bioxone September 12, 2020

–Ayooshi Mitra, Amity University Kolkata With the horror with which Covid-19 is spreading presently, the story of U.S President Donald Trump’s suggestion that the Coronavirus was either engineered intentionally or was the result of a laboratory accident at the Wuhan Institute of Virology in China, has brought forward terror in the minds of people.  According […]

Related Post

  • BiotechToday
  • World

VEGAN MILK vs ANIMAL DAIRY PRODUCTS

bioxone June 3, 2021June 2, 2021

Camelia Bhattacharyya, Amity University Kolkata There has always been a lot of debates surrounding vegan food. While some vegans at times drink milk, others show complete avoidance towards any kind of milk products including dairy as well. This might at times raise questions on the diet chart followed by the vegans. It is surely good […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Do we have a vaccine for HIV now?!!!

bioxone February 12, 2021February 12, 2021

CAMELIA BHATTACHARYYA, AMITY UNIVERSITY KOLKATA HIV or Human Immunodeficiency virus was first discovered in the early 1980s. It later became an epidemic and it still scares people since there’s still no vaccine known to protect us against it. Does that mean that the scientists and researchers are not trying to even make one? Well no. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

DRDO’s “2-DG” Anti-Covid Drug has been finally launched

bioxone May 18, 2021May 18, 2021

Anuska Sen, Team BioXone Abbreviations used in the following article: 2-DG: 2-deoxy-D-glucose DRDO: Defence Research and Development Organization INMAS: Institute of Nuclear Medicine and Allied Sciences DCGI: Drugs Controller General of India The 2-DG anti-covid drug jointly developed by DRDO’s INMAS laboratory and Dr. Reddy’s Laboratories has finally been launched yesterday (Monday, 17th May, 2021). […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy